Ron Martell - 12 Apr 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
President, CEO and Director, Director
Signature
/s/ Ronald A. Martell
Issuer symbol
JSPR
Transactions as of
12 Apr 2023
Net transactions value
-$127,795
Form type
4
Filing time
14 Apr 2023, 16:17:37 UTC
Previous filing
20 Mar 2023
Next filing
13 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Tax liability $127,795 -87,531 -17% $1.46 418,719 12 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares of the Issuer's common stock upon the vesting of restricted stock units.